DHX Company Co., Ltd. (KOSDAQ:031860)

South Korea · Delayed Price · Currency is KRW

6,930.00

+1,020.00 (17.26%)

At close: Apr 3, 2026

-39.48% (1Y)

Market Cap	13.15B -33.1%
Revenue (ttm)	13.93B +18.6%
Net Income	-32.29B
EPS	-17,890.50
Shares Out	1.90M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	376,887
Open	5,970.00
Previous Close	5,910.00
Day's Range	5,970.00 - 7,550.00
52-Week Range	2,020.00 - 17,830.00
Beta	-0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About DHX Company

DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution; and meditech distribution. In addition, the company is involved in manufacture and distribution of computers and peripherals; investment and asset ma... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 1979

Employees 23

Stock Exchange KOSDAQ

Ticker Symbol 031860

Full Company Profile

Financial Performance

In 2025, DHX Company's revenue was 14.51 billion, an increase of 52.05% compared to the previous year's 9.54 billion. Losses were -33.19 billion, 88.7% more than in 2024.

Financial Statements